Development Programs
Angiomax / Angiox (bivalirudin)
Cleviprex (clevidipine butyrate)
Cangrelor
CU2010
Oritavancin
HOME
Advancing Innovation in Critical Care
Please choose region
The Medicines Company (Nasdaq: MDCO)
Disclaimer
Privacy Policy
Copyright ©2009
Design by Checkmate Productions